BALLAST ADVISORS LLC

Position in NVO — Novo Nordisk A S

CIK 1803415 WOODBURY, MN

Position in NVO

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$942,164

+$150,275 QoQ

Shares Held

19,653

-8.8% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.59%

of 13F equity value

Holder Rank

#541

of 1,348 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 94% Shared 0% None 6%

Healthcare · as of Jun 30, 2026

BALLAST ADVISORS LLC holds $3,717,424 across 6 Drug Manufacturers - General names. NVO ranks #2 (25.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	3,791	$962,800
2	NVO	Novo Nordisk A S This page	19,653	$942,164
3	LLY	ELI LILLY & Co	452	$542,142
4	ABBV	AbbVie Inc.	2,140	$538,509
5	AMGN	Amgen Inc	1,297	$469,669
6	MRK	Merck & Co., Inc.	2,040	$262,140

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$942,164	19,653	-8.8%	Shares	Sole	2026-08-12
2026-03-31	$791,889	21,548	+0.9%	Shares	Sole	2026-05-13
2025-12-31	$1,086,745	21,359	-1.7%	Shares	Sole	2026-02-03
2025-09-30	$1,206,075	21,735	-0.7%	Shares	Sole	2025-11-12
2025-06-30	$1,511,054	21,893	+7.4%	Shares	Sole	2025-07-31
2025-03-31	$1,416,089	20,393	+10.5%	Shares	Sole	2025-05-07
2024-12-31	$1,587,499	18,455	+10.6%	Shares	Sole	2025-02-11
2024-09-30	$1,986,563	16,684	-3.2%	Shares	Sole	2024-10-30
2024-06-30	$2,461,408	17,244	+5.3%	Shares	Sole	2024-07-26
2024-03-31	$2,102,935	16,378	+3.1%	Shares	Sole	2024-05-01
2023-12-31	$1,643,820	15,890	+28.0%	Shares	Sole	2024-01-30
2023-09-30	$1,128,747	12,412	+373.4%	Shares	Sole	2023-10-19
2023-06-30	$424,318	2,622	+54.1%	Shares	Sole	2023-08-04
2023-03-31	$270,697	1,701	—	Shares	Sole	2023-05-09
No filing history on record for this holder in this stock.